Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Glossary for Female reproductive conditions

  • 46,XY Gonadal Dysgenesis, Complete, SRY-Related: A rare disorder where a female has all the normal external femal characteristics but has non-functioning gonads. This means that no sex hormones needed for puberty are produced. This particular type is the result of a defect in the SRY gene located on chromosome Yp11.3.
  • Acromegaly due to growth hormone-secreting pituitary adenoma: Pituitary adenomas are benign monoclonal neoplasms of the anterior pituitary gland, accounting for approximately 15% of intracranial tumors.
  • Adenomyosis: A rare disorder where the endometrium (lining of the uterus) grows inside the muscle walls of the uterus. The condition is generally harmless but can be very painful.
  • Adenosarcoma of the uterus: A tumor that develops from the glands that line the uterus.
  • Ahumada-Del Castillo Syndrome: A rare endocrine disorder characterized by dysfunction of the pituitary and hypothalamus glands in women.
  • Allergic seminal vulvovaginitis: Vaginal inflammation following contact with semen after ejaculation.
  • Amenorrhea: Absence of menstrual periods due to many possible causes.
  • Anovulation: Failure to ovulate
  • Autoimmune Endometriosis: An endometriosis that is caused by an autoimmune reaction
  • Autoimmune oophoritis: An autoimmune condition where the body's own immune system attacks the ovaries and causes them to become inflamed. It can lead to ovarian function stopping prematurely.
  • Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome, type 2: A rare genetic disorder characterized by inner canthal folds, lateral displacement of inner canthi and drooping upper eyelid. The severity of symptoms is variable. There are two subtypes of the condition: Type 2 involves eye anomalies as well as female fertility problems whereas type 1 only involves the eye anomalies.
  • Brenner tumor: A benign ovarian tumor
  • Cervical Cancer: Cervical cancer is malignant cancer of the cervix uteri or cervical area
  • Cervicitis: Inflammation of the cervix
  • Congenital adrenal hyperplasia -- simple virilizing form in females: A group of disorder that occur when a deficiency of 21-hydroxylase impairs the normal process of making adrenal corticosteroids. The simple virilizing form involves a moderate deficiency of 21-hydroxylase and differs in its effects on males and females.
  • Double uterus-hemivagina-renal agenesis: A very rare malformation of the uterus and vagina.
  • Dysfunctional Uterine Bleeding: Uterus bleeding unrelated to periods
  • Dysgerminoma: A rare form of cancer of the germ cells in the ovary. It is generally asymptomatic in the early stages. Prognosis with treatment is generally quite good.
  • Dysmenorrhea: Pain, cramping, or discomfort due to menstruation
  • Endometrial Cancer: Cancer of the endometrium (uterus lining).
  • Endometrial conditions: Conditions that affect the female endometrium that is located in the uterus
  • Endometrial hyperplasia: Thickening of the endometrium (lining of the uterus)
  • Endometrial stromal sarcoma: A rare type of cancer that develops from the endometrial layer of the uterus. The cancer may be slow-growing or aggressive and may metastasize.
  • Endometriosis: Misplaced uterus tissue causing scar tissue.
  • Endometritis: Inflammation of the endometrium (uterine lining)
  • Enterocele: Prolapse of the small bowel into the wall of the vagina, usually caused by past damage to the pelvic floor muscles.
  • FSH-resistant ovaries (FSH-RO): A recessively inherited disorder where the ovaries are unable to respond to the follicle stimulating hormone which results in symptoms such as lack of menstruation and infertility.
  • Fallopian tube cancer: A cancer that originates in the fallopian tubes which form part of the female reproductive organs. This type of cancer is relatively uncommon.
  • Female infertility: Infertility that affects the female
  • Female reproductive toxicity: There is mounting evidence which indicates that exposure to certain agents may produce adverse reproductive or fetal developmental effects. The possible range of effects includes reduced fertility, low birth weight, childhood cancer, spontaneous abortion and birth defects. Agents which may be implicated in these adverse effects includes anticancer drugs, carbon disulfide, carbon monoxide, lead, pesticides, organic solvents and tobacco smoke.
  • Female reproductive toxicity -- Acetaminophen: Taking excessive doses of acetaminophen during pregnancy can result in kidney and liver problems in the baby. Pregnant women should avoid taking more than the recommended amount of the drug.
  • Female reproductive toxicity -- Alcohol: There is some evidence which indicates that some women exposed to alcohol may suffer adverse effects as a result. Possible adverse effects due to chronic maternal alcohol exposure includes irregular menstrual cycle, fetal alcohol syndrome and physical and behavioral problems. Scientists have been unable to establish the quantity of alcohol required to cause reproductive toxicity.
  • Female reproductive toxicity -- Aminopterin: Exposure to Aminopterin, a recognized reproductive toxicant, can negatively affect the female reproductive system. Aminopterin is used as an anticancer drug. The severity and nature of the adverse effect is variable and can be influenced by factors such level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Arsenic: There is some evidence which indicates that some women exposed to inorganic arsenic may suffer adverse effects as a result. Spontaneous abortion and low birth weight are possible adverse effects.
  • Female reproductive toxicity -- Aspirin: Exposure to aspirin, a recognized reproductive toxicant, can negatively affect the female reproductive system. Aspirin is a drug used as a pain reliever. The severity and nature of the adverse effect is variable and can be influenced by factors such level of exposure and individual sensitivity to the chemical as well as stage of pregnancy. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Cadmium: There is some evidence which indicates that some women exposed to cadmium may suffer adverse effects as a result. Low birth weight is a possible adverse effect.
  • Female reproductive toxicity -- Carbon Monoxide: There is some evidence which indicates that some women exposed to carbon monoxide may suffer adverse effects as a result. Spontaneous abortion and low birth weight are possible adverse effects. Adverse effects are generally only likely to occur in cases involving chronic exposure to carbon monoxide.
  • Female reproductive toxicity -- Chlorination by-products: There is limited conflicting evidence which indicates that some women exposed to chlorination by-products may suffer adverse effects as a result. Spontaneous abortion, menstrual disorders and low birth weight are possible adverse effects. Adverse effects are generally only considered possible at higher concentrations or with chronic exposure.
  • Female reproductive toxicity -- Clobetasol Propionate: Exposure to Clobetasol Propionate, a recognized reproductive toxicant, can negatively affect the female reproductive system. Clobetasol Propionate is a corticosteroid used to treat skin conditions such as eczema and psoriasis. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Cocaine: Exposure to Cocaine, a recognized reproductive toxicant, can negatively affect the female reproductive system. Cocaine is used mainly as a recreational drug. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Dichlorodiphenyltrichloroethane (DDT): There is limited conflicting evidence which indicates that some women exposed to dichlorodiphenyltrichloroethane (DDT) may suffer adverse effects as a result. Spontaneous abortion and menstrual disorders, premature birth and neurodevelopmental disorders are the possible adverse effects.
  • Female reproductive toxicity -- Diflunisal: Exposure to Diflunisal, a recognized reproductive toxicant, can negatively affect the female reproductive system. Diflunisal is a drug used mainly to treat inflammation associated with arthritis. The severity and nature of the adverse effect is variable and can be influenced by factors such level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Dioxins: There is limited conflicting evidence which indicates that some women exposed to dioxins may suffer adverse effects as a result. Spontaneous abortion and menstrual disorders and birth defects are the possible adverse effects.
  • Female reproductive toxicity -- Electromagnetic Fields: There is some evidence which indicates that some women exposed to electromagnetic fields may suffer adverse effects as a result. Spontaneous abortion and childhood cancer are the possible adverse effects.
  • Female reproductive toxicity -- Ethylene Glycol ethers: There is some evidence which indicates that some women exposed to Ethylene Glycol ethers may suffer adverse effects as a result. Spontaneous abortion can occur in some women as a result of the exposure.
  • Female reproductive toxicity -- Ethylene Oxide: Exposure to Ethylene Oxide, a recognized reproductive toxicant, can negatively affect the female reproductive system. Ethylene Oxide is used in pesticides as well as disinfectants. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Etodolac: Exposure to Etodolac, a recognized reproductive toxicant, can negatively affect the female reproductive system. Etodolac is a drug used mainly to treat arthritic pain and inflammation. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Flunisolide: Exposure to Flunisolide, a recognized reproductive toxicant, can negatively affect the female reproductive system. Flunisolide is a corticosteroid drug used to treat such things as allergic rhinitis. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Flurbiprofen: Exposure to Flurbiprofen, a recognized reproductive toxicant, can negatively affect the female reproductive system. Flurbiprofen is a drug used mainly to treat inflammation associated with arthritis. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Goserelin Acetate: Exposure to Goserelin Acetate, a recognized reproductive toxicant, can negatively affect the female reproductive system. Goserelin Acetate is a drug often used to treat late-stage prostate cancer, endometriosis or symptoms of advanced breast cancer. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Haloperidol: Exposure to Haloperidol, a recognized reproductive toxicant, can negatively affect the female reproductive system. Haloperidol is an antipsychotic drug used to treat various psychotic disorders. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Ionizing radiation: There is some evidence which indicates that some women exposed to Ionizing radiation may suffer adverse effects as a result. Infertility, menstrual disorders, birth defects, spontaneous abortion and childhood cancer are possible adverse effects and are generally only considered possible in cases of chronic exposure.
  • Female reproductive toxicity -- Lead: There is some evidence which indicates that some women exposed to lead may suffer adverse effects as a result. Spontaneous abortion, infertility, premature birth, delayed puberty and neurobehavioral problems are possible adverse effects.
  • Female reproductive toxicity -- Leuprolide Acetate: Exposure to Leuprolide Acetate, a recognized reproductive toxicant, can negatively affect the female reproductive system. Leuprolide Acetate is a drug used mainly to treat advanced prostate cancer and breast cancer and endometriosis. The severity and nature of the adverse effect is variable and can be influenced by factors such as sex, level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Levonorgestrel Implants: Exposure to Levonorgestrel Implants, a recognized reproductive toxicant, can negatively affect the female reproductive system. Levonorgestrel Implants are used mainly as contraceptive. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Mercury: There is strong evidence which indicates that some women exposed to mercury may suffer adverse effects as a result. Spontaneous abortion, infertility, premature birth, delayed puberty and neurobehavioral problems are possible adverse effects.
  • Female reproductive toxicity -- Nifedipine: Exposure to Nifedipine, a recognized reproductive toxicant, can negatively affect the female reproductive system. Nifedipine is used mainly to treat angina and high blood pressure. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Organic solvents: There is limited conflicting evidence which indicates that some women exposed to Organic solvents may suffer adverse effects as a result. Menstrual disorders, fertility problems, spontaneous abortion and birth defects are possible adverse effects and are generally only considered possible in cases of chronic exposure.
  • Female reproductive toxicity -- Pesticides: There is limited evidence which indicates that some women exposed to pesticides may suffer adverse effects as a result. Spontaneous abortion, infertility, menstrual disorders and birth defects are possible adverse effects. Generally, adverse effects are only likely to occur with chronic exposure such as occurs in occupational settings e.g. farm workers.
  • Female reproductive toxicity -- Phthalates: There is conflicting evidence which indicates that some women exposed to phthalates may suffer adverse effects as a result. Premature birth, structural defects and premature breast development are possible adverse effects. No firm link has been proven and adverse effects are only considered likely in cases of chronic exposure.
  • Female reproductive toxicity -- Physical stress: There is limited conflicting evidence which indicates that some women exposed to physical stress may suffer adverse effects as a result. Premature birth, low birth weight and spontaneous abortion are possible adverse effects.
  • Female reproductive toxicity -- Pimozide: Exposure to Pimozide, a recognized reproductive toxicant, can negatively affect the female reproductive system. Pimozide is used mainly as an antipsychotic drug. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Polyaromatic hydrocarbons (PAHs): There is limited conflicting evidence which indicates that some women exposed to polyaromatic hydrocarbons may suffer adverse effects as a result. Low birth weight and small birth size are possible adverse effects and are generally only considered possible in cases of chronic exposure.
  • Female reproductive toxicity -- Polychlorinated biphenyls (PCBs): There is limited conflicting evidence which indicates that some women exposed to Polychlorinated biphenyls may suffer adverse effects as a result. Low birth weight, hyperpigmentation and menstrual disorders are possible adverse effects and are generally only considered possible in cases of chronic exposure.
  • Female reproductive toxicity -- Streptozotocin: Exposure to Streptozotocin, a recognized reproductive toxicant, can negatively affect the female reproductive system. Streptozotocin is a drug used to treat pancreatic islet cell cancer. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Sulindac: Exposure to Sulindac can negatively affect the female reproductive system. Sulindac is a drug used mainly to treat pain and inflammation associated with arthritis. The severity and nature of the adverse effect is variable and can be influenced by factors such as level of exposure and individual sensitivity to the chemical. Effects on the female reproductive systems can include such things as menstrual problems, altered sexual behavior, infertility, altered puberty onset, altered length of pregnancy, lactation problems, altered menopause onset and pregnancy outcome.
  • Female reproductive toxicity -- Tobacco smoke: There is some evidence which indicates that some women exposed to tobacco smoke may suffer adverse effects as a result. Fertility problems, fetal death, low birth weight and SIDS are possible adverse effects and are generally only considered possible in cases of chronic exposure.
  • Female reproductive toxicity -- Video display Terminals (VDT): Despite persistent concerns there is no evidence that links female exposure to video display terminals with reproductive problems. Various studies have found no link between the two exists.
  • Female reproductive toxicity -- anesthetic gases: There is some evidence which indicates that women exposed to excessive levels of anesthetic gases may suffer adverse reproductive or fetal developmental effects. Such effects are unlikely to occur except in cases where high occupational exposure results from sub-standard controls in occupational settings.
  • Female reproductive toxicity -- antineoplastic drugs: There is some evidence which indicates that some women exposed to anticancer drugs may suffer adverse effects as a result. The exposure may occur through the obvious route of having to take the drug to treat cancer but may also inadvertently occur in workplace environments which involves handling the anticancer drugs - e.g. pharmacists who mix the drugs or nursing staff who administer the drug. Spills and improper handling of the substance are the most likely scenarios for inadvertent exposure. The dental, medical and veterinary occupational settings are most common sources of exposure. Spontaneous abortion and birth defects are some of the possible adverse effects.
  • Florid cystic endosalpingiosis of the uterus: Benign tumor-like uterine cysts.
  • Follicle-stimulating hormone deficiency, isolated: A genetic disorder characterized by the deficiency of follicle-stimulating hormone which primarily affects fertility.
  • Fowler-Christmas-Chapple syndrome: A rare syndrome characterized by the association of polycystic ovaries with the abnormal functioning of the urinary valve.
  • Glassy cell carcinoma of the cervix: A rare type of cervical cancer.
  • Gonadal dysgenesis, XX type: A rare genetic condition involving non-functional ovaries causing a failure of puberty due to the lack of production of sex hormones by the ovaries.
  • Granulosa cell tumor of the ovary: A rare type of ovarian tumor which can cause excess estrogen hormone production. The tumor is a low grade malignant tumor.
  • Gynaecological conditions: Any condition the affects the female reproductive organs
  • Gynandroblastoma: A type of ovarian tumor that causes feminizing and masculinizing effects of estrogen and androgen.
  • HAIR-AN Syndrome: A very rare syndrome that affects females only and is characterized mainly by insulin resistance, dark velvety patches of skin and increased male hormone production in females.
  • Hypergonadotropic ovarian failure: Premature onset of menopause - occurs before the fourth decade -average age of onset of menopause is about 50 years of age. The condition can occur sporadically or may be inherited in a familial manner.
  • Hypergonadotropic ovarian failure, familial or sporadic: A rare disorder where the ovaries fail to function prematurely. Ovarian failure can occur in the 20's or 30's. Normal ovarian failure occurs during menopause. Premature ovarian failure can be caused by a genetic mutation and can occur sporadically or in a familial pattern.
  • Hypoplastic thumb -- mullerian aplasia: A rare disorder characterized by an underdeveloped thumb, vertebral abnormalities and abnormal development or lack of a part of the female reproductive system (uterus, cervix and upper vagina). The external genitalia appear normal and the ovaries usually function normally.
  • Hypothalamic amenorrhea: A condition which is characterized by amenorrhea caused by a an abnormality of the hypothalamus
  • Hysterectomy: The surgical removal of the female uterus
  • IBS associated with endometriosis: IBS is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the presence of endometriosiis which is characterised by the ectopic presence of endometrial tissue in various parts of the body.
  • Intrauterine infections: Infection of the fetus while still inside the womb. The type and severity of symptoms is determined by the type of infection and at what stage of pregnancy it occurs. Some cases are mild enough to be asymptomatic and others are severe enough to cause a miscarriage.
  • Klippel Feil deformity conductive deafness absent vagina: A rare developmental disorder occurring only in females and characterized by skeletal and genitourinary abnormalities and small stature.
  • Klotz syndrome: A rare syndrome characterized mainly by absent menstruation, infantile genitals and other sexual organ abnormalities in females who are genetically male.
  • Krukenberg carcinoma: A form of ovarian cancer.
  • Labor Pain: Pain that occurs during active childbirth.
  • Labor, Premature: Labor that occurs before the pregnancy has reached full term i.e. before the 37th week of pregnancy. The degree of prematurity will determine the outcome of the infant.
  • Lactotroph adenoma: A benign pituitary tumor that secretes excessive prolactin which can affect the functioning of the reproductive system - testes and ovaries. The tumor may also grow large enough to compress adjacent structures such as the eye nerves.
  • MRKH syndrome: A syndrome characterized mainly by the failure of the uterus and most of the upper vagina to develop during the fetal stage. Females tend to develop secondary sexual characteristics with functioning ovaries but don't menstruate.
  • Mayer-Rokitansky-Kuster-Hauser, syndrome, type 2 (MRKH type 2): A rare developmental disorder occurring only in females and characterized by skeletal and genitourinary abnormalities and small stature.
  • Menarche: The beginning of a females menstrual function
  • Menopause: The end of female menstruation and fertility.
  • Menstrual conditions: Any condition that is associated with the female menstrual cycle
  • Menstruation: The passage of blood and uterine tissue through the vagina cyclically
  • Metrorrhagia: Uterine bleeding that does not occur during the normal menstrual cycle. It can be caused by such things as hormonal abnormalities and tumors.
  • Michels-Caskey syndrome: A very rare disorder characterized by underdeveloped thumbs, spine deformities and lack of development of the female reproductive organs such as the uterus and vagina (mullerian duct aplasia). The external genitalia may appear to be normal.
  • Miscarriage: Loss of fetus without human interference
  • Mittelschmerz: Mid-cycle abdominal pain due to ovulation
  • Myoma (fibroid): A benign tumour of the muscle in the wall of the uterus.
  • OHSS: Excessive stimulation of the ovaries that usually occurs as a complication of in vitro fertilization but may also occur spontaneously. The degree of excessive ovarian stimulation may vary from mild to severe.
  • Obstetrical conditions: Any condition that occurs during the process of being pregnant or delivering a baby
  • Oligodontia and polycystic ovarian syndrome: A rare syndrome characterized by the association of missing teeth and polycystic ovarian syndrome.
  • Oligomenorrhea: A medical term that refers to light or infrequent menstrual periods. The condition can be caused by a number of disorders including Graves disease, thyrotoxicosis or a pituitary tumor.
  • Oophoritis: Ovary inflammation
  • Osteosclerosis -- ichthyosis -- premature ovarian failure: A very rare syndrome characterized mainly by increased bone density, scaly skin and premature menopause.
  • Osteosclerosis with ichthyosis and premature ovarian failure: A very rare syndrome characterized mainly by increased bone density, scaly skin and premature menopause.
  • Osteosclerosis with ichtyhosis and premature ovarian failure:
  • Ovarian Cancer: Cancer of the ovaries.
  • Ovarian carcinosarcoma: A type of ovarian cancer.
  • Ovarian cysts: Cysts occurring in the ovaries.
  • Ovarian epithelial cancer: Development of cancer in the tissue of the outer covering of the ovaries.
  • Ovarian germ cell malignant tumor: Development of cancer in the tissue of the eggs (germ cells) in the ovaries.
  • Ovarian germ cell tumor: Development of cancer in the tissue of the eggs (germ cells) in the ovaries.
  • Ovarian insufficiency due to FSH resistance: A rare disorder where the ovaries fail to function normally as they are unable to respond to follicle stimulating hormones.
  • Ovarian insufficiency, familial: A rare inherited disorder where the ovaries fail to function normally despite normal levels of hormones that stimulate ovarian activity. Ovarian failure is a normal phase of aging and is associated with menopause but it is termed ovarian insufficiency when it occurs in a female under the age of 40.
  • Ovarian low malignant potential tumor: An ovarian tumor that may or may not become malignant.
  • PID-like dyspareunia: Pain during sexual intercourse.
  • Pelvic Inflammatory Disease: Infection of the womb and fallopian tubes.
  • Perimenopause: The start of onset of menopause
  • Polycystic ovarian disease, familial: A rare familial condition characterized by menstrual abnormalities, excessive growth of hair, obesity and infertility.
  • Polycystic ovaries urethral sphincter dysfunction: A rare syndrome characterized by the association of polycystic ovaries with the abnormal functioning of the urinary valve.
  • Polycystic ovary syndrome: Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 5% of all women.
  • Pregnancy-related conditions: Any condition that is related to or caused by pregnancy
  • Premature Ovarian Failure 1: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 1 is linked to a genetic anomaly on chromosome Xq26-q28.
  • Premature Ovarian Failure 2: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 2 is linked to a genetic anomaly on chromosome Xq13.3-q21.1.
  • Premature Ovarian Failure 2A: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 2A is linked to a defect in the DIAPH2 gene on chromosome Xq22.
  • Premature Ovarian Failure 2B: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 2B is linked to a defect in the POF2B gene on chromosome Xq21.
  • Premature Ovarian Failure 3: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 3 is linked to a genetic anomaly on chromosome 3q23.
  • Premature Ovarian Failure 4: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 4 is linked to a genetic anomaly on chromosome Xp11.2.
  • Premature Ovarian Failure 5: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 5 is linked to a genetic anomaly on chromosome 7q35.
  • Premature Ovarian Failure 6: A condition where menopause occurs earlier than normal due to premature loss of function of the ovaries. Premature menopause refers to menopause occurring before the age of 40 years with the average age of menopause occurring about the age of 50 years. Type 6 is linked to a genetic anomaly on chromosome 2p12.
  • Premature ovarian failure, familial: A familial condition where menopause tends to occur before the fourth decade -average age of onset of menopause is about 50 years of age.
  • Premenstrual syndrome: Condition with cyclic symptoms related to menstruation.
  • Primary Dysmenorrhea: Painful menstruation which is not associated with pelvic pathology
  • Primary Fallopian Tube Cancer: A cancer that originates in the fallopian tubes which form part of the female reproductive organs. This type of cancer is relatively uncommon.
  • Primary amenorrhea: Never starting menstruation at puberty
  • Renon-Delille syndrome: A rare syndrome characterized by reduced function of the thyroid and ovaries and enlarged hands and feet.
  • Reproductive conditions: Medical conditions of the reproductive system in men or women.
  • Retroverted uterus: The tipping back in the position of the uterus in the female pelvis
  • Rokitansky sequence: A very rare syndrome characterized mainly by the absence of various internal reproductive structures.
  • Rokitansky-Kuster-Hauser syndrome: A rare condition characterized by absence of the vagina and uterine abnormalities.
  • Salpingitis: Inflammation of the fallopian tubes
  • Secondary Dysmenorrhea: Menstrual-like cramping (dysmenorrhea) from an underlying condition.
  • Secondary Fallopian Tube Cancer: A cancer that originates in some other part of the body and metastasizes to the fallopian tubes which form part of the female reproductive organs. This type of cancer is relatively uncommon.
  • Semen allergy: An allergic reaction to the semen of a sexual partner. The reaction may be localized or systemic.
  • Stampe-Sorensen syndrome: A rare uterine abnormality which affects fertility in women.
  • Tubal ligation syndrome: A complication that can occur after sterilization using tubal ligation in females.
  • Unusual facies, renal and Mullerian hypoplasia and severe somatic and mental retardation: A rare syndrome characterized mainly by underdeveloped kidneys and Mullerian structures, unusual facial appearance and severe somatic and mental retardation.
  • Uterine Cancer: Cancer of the uterus.
  • Uterine fibroids: Benign nodules in the uterus wall.
  • Uterine prolapse: Prolapse of the uterus into the wrong position
  • Uterine sarcoma: A rare type of cancer that occurs in the uterus or associated tissues. A sarcoma is a cancer that involves soft tissue and connective tissue such as bone, cartilage, fat, muscle and blood vessels.
  • Vagina, absence of: A condition characterised by the absence of a vagina at birth
  • Virilising ovarian tumour: A tumour that results in the virilization of females due to hormone release
  • Virilizing ovarian tumor: An ovarian tumor made up of hormone secreting cells which results in excessive male hormone (androgen) production.
  • Vulvar neoplasms: A tumor that develops in the tissue of the vulva.
  • XY female: A person who has a chromosome composition of 46 XY and who is phenotypically female

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise